Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes
Wednesday 12 March 2025, 12:55 AM
14 minutes to Read
Patients might be concerned about what they read and hear in the news regarding the use of renin–angiotensin system blockers during the COVID-19 pandemic. Cardiologist Chris Ellis reviews recent research and current recommendations
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.